Johnson & Johnson Settlement Offer Solidifies

The Articulated Surface Replacement, or ASR, hip replacement device may cost Johnson & Johnson less than originally anticipated. After a reported tentative offer of over $4 billion, the lawyers for Johnson & Johnson reportedly went to work negotiating a new settlement offer at a reduced figure of $2.56 billion. However, the reduction does not tell the complete story, as separate suits could still be filed for pain and damages, which makes this a base figure that does not fully represent the total sum that could eventually be paid out. For more dialogue on this case, see the New York Times article here.